News & Insights

Cases & Deals

August 2, 2019

Akston Biosciences Corporation Signs Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

On August 2, 2019, King & Spalding advised Akston Biosciences Corporation in connection with a licensing and supply agreement with Dechra Pharmaceuticals PLC under which the companies will jointly complete the development of a long acting protein for the treatment of diabetes in dogs. Akston is a leader in the field of insulin engineering.